Introducing the CxO system effective April 1, 2026, establishing roles of CEO, COO, CMSO, CTO, CPO, CFO, and CHRO. Resolutions on changes in executive officers\u2019 titles and concurrent roles.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4549","jir_company_name":"Eiken Chemical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-02-26","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4549-20260226-01.pdf","jir_short_summary":"Introducing the CxO system effective April 1, 2026, establishing roles of CEO, COO, CMSO, CTO, CPO, CFO, and CHRO. Resolutions on changes in executive officers\u2019 titles and concurrent roles.","jir_summary":"### Overview of the Introduction of the CxO System\nEiken Chemical Co., Ltd. will introduce the CxO system effective April 1, 2026, establishing seven roles: CEO, COO, CMSO, CTO, CPO, CFO, and CHRO. This system appoints executives with expertise in core management areas to enhance the quality of management decisions and accelerate decision-making. The aim is to build a robust management foundation and achieve sustainable enhancement of corporate value.\n\n### Changes in Executive Officers and Title Modifications\nEffective April 1, 2026, executive officers\u2019 titles will be changed and multiple executives will concurrently hold CxO roles. Representative Executive Officer President Yuji Segawa will concurrently serve as CEO and COO, Executive Officer Senior Managing Director Yoshiyoshi Moriyasu will concurrently serve as CTO. Additionally, the Head of Production will concurrently serve as CPO, the Head of Sales as CMSO, and the Head of Corporate Management as CFO and CHRO, transitioning to a system that strengthens management specialization and facilitates prompt decision-making.","jir_financial_highlights":"Introduction Date: 2026-04-01 (New Establishment)\nEstablished Roles: CEO, COO, CMSO, CTO, CPO, CFO, CHRO (New Establishment)\nRepresentative Executive Officer President Yuji Segawa\u2019s Position: Representative Executive Officer President concurrently CEO and COO (Title Change and Concurrent Roles)","jir_category":"","jir_hashtags":"#EikenChemicalCoLtd, #executive_change, #JapanStocks","jir_key_figures":"Introduction Date: 2026-04-01\nNumber of Established Roles: 7 (CEO, COO, CMSO, CTO, CPO, CFO, CHRO)\nRepresentative Executive Officer President Yuji Segawa\u2019s Position: Representative Executive Officer President concurrently CEO and COO","jir_meta_title":"Eiken Chemical Announces Introduction of CxO System and Executive Changes Effective April 1, 2026","jir_meta_description":"Eiken Chemical Co., Ltd. will introduce the CxO system on April 1, 2026, establishing seven roles including CEO, COO, and CMSO. Resolutions passed on changes in executive titles and concurrent roles to strengthen management expertise and accelerate decision-making.","jir_og_title":"Eiken Chemical Announces Introduction of CxO System and Executive Changes","jir_og_description":"Effective April 1, 2026, the CxO system will be introduced, with changes in executive officers\u2019 titles and concurrent roles decided to improve management decision quality and speed.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16754,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-31491","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n